Cosmetic uses of botulinum toxin type B

Cosmetic Dermatology

Volumn 15, Issue 2, 2002, Pages 11-14

  Spencer, James M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; BOTULINUM TOXIN B;

BLEPHAROSPASM; DOSE RESPONSE; DRUG MARKETING; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERANCE; DYSTONIA; FACE MUSCLE; FOOD AND DRUG ADMINISTRATION; FREEZE DRYING; FREEZING; HEMIFACIAL SPASM; HUMAN; PARALYSIS; PH; REVIEW; ROOM TEMPERATURE; SPASMODIC TORTICOLLIS; STRABISMUS; UNITED STATES;

EID: 0012648894     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Setler P. The biochemistry of botulinum toxin type B. Neurology. 2000;55(12, suppl 5):S22-S28.
2. Callaway JE, Arezzo JC, Grethlein AJ. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology. Semin Cutan Med Surg. 2001;20:127-136.
3. Carruthers A, Carruthers J. Toxins 99: new information about the botulinum neurotoxins. Dermatol Surg. 2000;26:174-176.
4. Patarnello T, Bargelloni L, Rossetto O, et al. Neurotransmission and secretion. Nature. 1993;364:581-582.
5. Moyer ED, Stephens EA, Esch F, et al. Effects of intramuscular injection of botulinum toxin type B in nonhuman primates. In: DasGupta BR, ed. Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects. New York, NY: Plenum Press; 1993:655-656.
6. Adler CH, Kumar R. Pharmacological and surgical options for the treatment of cervical dystonia. Neurology. 2000;55(12, suppl 5):S9-S14.
7. Lew MF, Adornato BT, Duane DD, et al. Botulinum toxin type B: a double-blind, placebo controlled, safety and efficacy study in cervical dystonia. Neurology. 1997;49:701-707.
8. Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A responsive cervical dystonia. Neurology. 1999;53:1439-1446.
9. Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology. 1999;53:1431-1438.
10. Comella C. Botox for cervical dystonia. Presented at: International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins; November 16-18, 1999; Orlando, Fl.